A Study to Promote Shared Decision Making of Treatment Choices in Patients who have Advanced Kidney Disease

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-005457
    • Scottsdale/Phoenix, Arizona: 16-005457
    • Jacksonville, Florida: 16-005457
    Sponsor Protocol Number: 16-005457

About this study

The purpose of this study is to develop educational materials that will help patients and clinicians talk about treatment options for patients with advanced kidney disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Seen for Chronic kidney disease 5 or End stage renal disease
  • Age > 55 years old 
  • Has mild cognitive impairment defined as a Montreal Cognitive Assessment score (MOCA) of  > 21 and < 26
  • Has a cognitively intact caregiver who is also willing to participate in the study

Exclusion Criteria

  • Has advanced dementia, MOCA < 21, or delirium as assessed by the validated Confusion Assessment Method
  • Any language barrier

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Bjoerg Thorsteinsdottir, M.D.

Open for enrollment

Contact information:

Susan Curtis M.L.S.

7762311

Curtis.Susan@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mira Keddis, M.D.

Open for enrollment

Contact information:

Narcelle Jean-Louis

7914714

JeanLouis.Narcelle@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Bjoerg Thorsteinsdottir, M.D.

Contact us for the latest status

Contact information:

Susan Curtis M.L.S.

7762311

Curtis.Susan@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20301658

Mayo Clinic Footer